companies innovating in obesity treatment glp-1 drugs 2025 💰 US & Europe. Biggest drug race medical history. 3 frontiers. All accelerating NOW. 🟢 Approximately $100 billion market. Eli Lilly: $1 TRILLION market cap. Oral pill FDA approved GLP-1 Antagonists Increase Plan Drug

Spallarossa P, Brunelli C, Minuto F, Caruso D, Battistini M, Caponnetto S, Cordera R: Insulin-like growth factor-I and angiographically documented coronary artery disease

Effects of Evening Exercise on Sleep in Healthy Participants: A Systematic Review and Meta-Analysis

Cindy Mosbreer: Well, and worse than giving people birth control without a diagnosis, ACOG says it's fine to give them Lupron without a diagnosis

A more nuanced finding comes from Crill et al., who observed that preterm infants receiving PN with L-carnitine supplementation achieved weight gain 5 days earlier than the placebo group

References: Buford TW, Kreider RB, Stout JR, Greenwood M, Campbell B, Spano M, Ziegenfuss T, Lopez H, Landis J, Antonio J

MMNST, formerly known as Melanotic Schwannoma or Schwannian melanotic tumor, was classified as a malignant lesion in the 2020 WHO classification of soft tissue tumors ( MMNST generally arises from spinal nerves and sympathetic ganglia as a single lesion ( The clinical presentation of spinal MMNST is related to its anatomical location